Woodside Capital says MedTech M&A shifts to transformative scale deals in Q2 2026

Woodside Capital Partners published its MedTech Market Update for Q2 2026 on Aug. 30, 2026, flagging a shift into sustained sector expansion.

• The report points to aging demographics and capital concentration in higher-margin categories as key drivers, including robotic surgery and minimally invasive technology.
• Strategic buyers dominated M&A, highlighted by Danaher’s $9.9 billion deal for Masimo to add AI-enabled patient monitoring capabilities.
• Venture funding rose to $3.8 billion for the quarter, with capital directed toward AI diagnostics, digital health and precision medicine.
• AI adoption broadened into operations as at-home diagnostics growth met tighter FDA quality requirements, reshaping device lifecycle risk management.